Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL23853

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Clc1ccc(CNCCCCNCc2ccc(Cl)c(Cl)c2)cc1Cl

Basic Information

ChEMBL ID CHEMBL23853
Phase Preclinical
Structure Type MOL
InChI Key UGGDWCZDSWVSRI-UHFFFAOYSA-N
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

406.2
MW (Da)
5.96
ALogP
2
HBA
2
HBD
24.1
PSA (Ų)
0.50
QED
1
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C18H20Cl4N2
MW 406.18
Aromatic Rings 2
Heavy Atoms 24
NP-Likeness -0.71

Activity Summary

IC50 2 meas. best 4.7

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PC-3
CHEMBL390
IC50 4.7 4.7 20000.0 1
MDA-MB-231
CHEMBL400
IC50 4.19 4.19 65000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PC-3 IC50 = 20000.0 nM 4.7 Inhibition of human prostate cancer cell line PC-3 growth 11965367
MDA-MB-231 IC50 = 65000.0 nM 4.19 Inhibition of human breast cancer cell line MDA-MB-231 growth 11965367

Literature References

PubMed DOI Target Context # Activities
11965367 10.1016/s0960-894x(02)00156-7 MDA-MB-231 1
11965367 10.1016/s0960-894x(02)00156-7 PC-3 1

Data from ChEMBL 36 via Core Engine